Skip to main content

Aligos ALG-184-202_HBV A Randomized, Double-Blind, Active-Controlled Multicenter Phase 2 Study Evaluating the Efficacy and Safety of ALG-000184 Compared with Tenofovir Disoproxil Fumarate in Untreated HBeAg-Positive and HBeAg-Negative Adult

Clinical Trial Grant
Duke Scholars

Administered By

Medicine, Gastroenterology

Awarded By

Aligos Therapeutics, Inc.

Start Date

October 2, 2025

End Date

May 31, 2030
 

Administered By

Medicine, Gastroenterology

Awarded By

Aligos Therapeutics, Inc.

Start Date

October 2, 2025

End Date

May 31, 2030